Splenocytes derived from young WT mice prevent AD progression in APPswe/PSENldE9 transgenic mice

Fei Wang; Xueyan Shen; Shuping Li; Long Chen; Yanru Wang; Jie Qin; Guomin Zhou; Yuwen Peng; Xiaoyuan Feng; Ruixi Li; Chunmin Liang

doi:10.18632/oncotarget.4930

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers: Gerotarget (Focus on Aging):

Splenocytes derived from young WT mice prevent AD progression in APPswe/PSENldE9 transgenic mice

Fei Wang, Xueyan Shen, Shuping Li, Long Chen, Yanru Wang, Jie Qin, Guomin Zhou, Yuwen Peng, Xiaoyuan Feng, Ruixi Li and Chunmin Liang _

PDF | HTML | How to cite

Oncotarget. 2015; 6:20851-20862. https://doi.org/10.18632/oncotarget.4930

Metrics: PDF 2450 views | HTML 2693 views | ?

Abstract

Fei Wang1,*, Xueyan Shen1,*, Shuping Li2,3,*, Long Chen1, Yanru Wang1, Jie Qin1, Guomin Zhou1, Yuwen Peng1, Xiaoyuan Feng2, Ruixi Li1, Chunmin Liang1

1Department of Anatomy and Histology & Embryology, Shanghai Medical College of Fudan University, Shanghai, P. R. China

2Department of Radiology, Huashan Hospital, Fudan University, Shanghai, P. R. China

3Department of Radiology, PLA No.455 Hospital, Shanghai, P. R. China

*These authors have contributed equally to this work

Correspondence to:

Chunmin Liang, e-mail: [email protected]

Keywords: Gerotarget, Alzheimer’s disease, splenocytes, immunosenescence, GDF11, Treg

Received: June 25, 2015 Accepted: July 24, 2015 Published: August 06, 2015

ABSTRACT

Immunosenescence contributes to pathogenesis of Alzheimer's disease (AD) in the elderly. In this study, we explored the effects of young wild type (WT) splenocytes (ySCs) on Alzheimer's disease by transplanting ySCs into APPswe/PSENldE9 transgenic mice. Young WT splenocytes not only prevented AD, but also improved the spatial learning and memory of APPswe/PSENldE9 transgenic mice. Young WT splenocytes enhanced Aβ clearance, decreased astrogliosis and increased systemic growth differentiation factor 11 (GDF11) levels. Splenocytes derived from old AD mouse promoted AD. There was an increased number of regulatory T cells (Tregs) among old AD splenocytes. We suggest that alterations of GDF11 and Tregs are involved in AD progression and that rejuvenation of the immune system is a potential therapeutic strategy in AD.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 4930

Publication Alerts

Research Papers: Gerotarget (Focus on Aging):

Splenocytes derived from young WT mice prevent AD progression in APPswe/PSENldE9 transgenic mice

Abstract